Accepted for Publication: December 5, 2022.
Published Online: April 27, 2023. doi:10.1001/jamaoncol.2023.0031
Corresponding Author: Alison L. Young, School of Medicine and Public Health, University of Newcastle, University Drive, Callaghan, New South Wales 2308, Australia (alison.young@newcastle.edu.au).
Author Contributions: Dr Young had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Paul, McCarter, McEnallay, Tait, Vinod, White.
Acquisition, analysis, or interpretation of data: Young, Stefanovska, Paul, McCarter, McEnallay, Tait, Day, Stone.
Drafting of the manuscript: Stefanovska, Paul, Tait.
Critical revision of the manuscript for important intellectual content: Young, Stefanovska, Paul, McCarter, McEnallay, Vinod, White, Day, Stone.
Statistical analysis: Young, Stefanovska.
Obtained funding: Paul, Vinod, White.
Administrative, technical, or material support: McEnallay, Tait.
Supervision: Young, Paul, White.
Conflict of Interest Disclosures: Dr Paul reported grants from the Cancer Institute of New South Wales outside the submitted work. Dr Vinod reported personal fees from AstraZeneca and Merck Sharp & Dohme outside the submitted work. Dr Day reported personal fees from Amgen; nonfinancial support from Bristol Myers Squibb, AstraZeneca, and Merck; and grants from Varian Medical Systems. No other disclosures were reported.
Funding/Support: This project is funded by the National Health and Medical Research Council (APP1169324).
Role of the Funder/Sponsor: The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Additional Contributions: Thank you to Zoe Benson, Sarah Morris, and Della Yates for their contribution to editing the draft manuscript.
Additional Information: The review protocol is registered with the International Prospective Register of Systematic Reviews (PROSPERO: CRD42020207463).